Browse our collection of papers in
GlaxoSmithKline (GSK)
C/N/297. GlaxoSmithKline (GSK) and Production of Swine Flu Vaccines
- WORDS:
- 2800
- DATE:
- 2009
- PRICE:
- 29.99 GBP
The paper addresses the issue of combating the global flu epidemic of Swine flu (H1N1) using a case study of the GSK vaccine unit. Analysis is conducted of the production of regular and swine flu vaccines using the PESTEL model, pharmaceutical industry life cycle analysis, Porter’s Five Forces and SWOT analysis of the GSK vaccine unit, analysis of the unique resources of the GSK vaccine unit, etc. The risk of dividing production between regular vaccine and swine flu vaccine is discussed suggesting the production of both regular and swine flu vaccines by GSK’s vaccine unit.
KEYWORDS: GlaxoSmithKline, GSK, Swine Flu Vaccines, SWOT, Porter’s five forces, PESTEL, Value Chain,
Other Papers On: Drugs and Pharmacology
Other Papers On: Strategic Analysis
Other Papers On: GlaxoSmithKline (GSK)
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
Keywords Tag Cloud
glaxosmithkline gsk management dissertation merger financial strategic mergers pharmaceutical change om plc study glaxo beecham performance aquafresh wellcome corporate smithkline operations effects desired acquisition proposal bring astrazeneca market social system value strategy global quality glaxowellcome stock pestel organisational vs managing johnson faced responsibility issues glaxosmithklein healthcare innovation audit intelligence shoeshine safety clinical molecular uk technical environmental disclosures model impact newspaper annual reports flu vaccines directions swine production publicity novartis capability credit operational opportunities investment rating marketing organisations phytopharm reasons swot mix measuring capm security theory disaster using pfizer studies hr shoring india arising challenges communication companies smithline process critical speeding price lean valuation approach backgrounds risk current share comparative benefits implementation development knowledge culture methodology systems soft harbin project role intellectual property innovations negotiation position options british petroleum control construction company portfolio stocks acquisitions critique equilibrium post pre pharmaceuticals final entrepreneurship finance master international investigation overview effect announcement economic benefit glaxosmithklines return c prediction
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
I recently purchased E/M/45 and P/M/512 from courseworks4you. The papers are extremely well written and worth every penny. Thank you!Patel
